See also this year's filing and all EDGAR filings for this company.
PDF Report 0000835887_2019_Progenics_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000835887, Progenics Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 144,129,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 19,740,000 |
| 2 | PropertyPlantAndEquipmentNet | 3,944,000 |
| 3 | remainder_Assets | 1,684,000 |
| 4 | LiabilitiesCurrent | 23,446,000 |
| 5 | LiabilitiesNoncurrent | 40,998,000 |
| 6 | remainder_Liabilities | 3,978,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 29,252,343 |
| 9 | ResearchAndDevelopmentExpense | 35,545,926 |
| 10 | remainder_Expenses | 6,702,219 |
| 11 | remainder_Revenues | 14,289,760 |
| 12 | remainder_NetIncome | -3,254,763 |
| 13 | remainder_ComprehensiveNetIncome | 51,999 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 169,497,000 |
| 1 | Liabilities | 68,422,000 |
| 2 | Expenses | 71,500,488 |
| 3 | Revenues | 14,289,760 |
| 4 | StockholdersEquity | 101,075,000 |
| 5 | NetIncome | -60,465,491 |
| 6 | ComprehensiveNetIncome | -60,439,492 |
| 7 | BaseVar | 163,508,005 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.34 |
| 9 | EconomicCapitalRatio | 2.56 |
Edgar->Model Mapping
Feature Distribution
Change over Time
